Terms ending in 2029
Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,298,536 | Methods of Treating Inflammatory Pain In force · High confidence | Teva Pharmaceuticals International GmbH | In force | High confidence | |
| US 9,328,167 | Methods of Treating Chronic Pain In force · High confidence | Teva Pharmaceuticals International GmbH | In force | High confidence | |
| US 10,323,085 | Methods of Treating Fibromyalgia In force · High confidence | Pfizer Limited | In force | High confidence | |
| US 8,293,239 | Methods of Treating Chronic Pain In force · High confidence | Teva Pharmaceuticals International GmbH | In force | High confidence | |
| US 8,491,915 | Heat Treated Bacterins, and Emulsion Vaccines Prepared from Such Heat Treated Bacterins In force · High confidence | Zoetis Services LLC | In force | High confidence | |
| US 9,221,915 | Human Monoclonal Antibodies to Activin Receptor-Like KINASE-1 In force · High confidence | Amgen Fremont Inc. | In force | High confidence | |
| US 7,960,515 | Binding Molecules to the Human OX40 Receptor In force · High confidence | Bristol-Myers Squibb Company | In force | High confidence | |
| US 7,795,243 | Penem Prodrugs In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 8,318,208 | Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| US 8,912,212 | Therapeutic Polymeric Nanoparticle Compositions with High Glass Transition Temperature or High Molecular Weight Copolymers In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| 21 more term ends in 2029 · Pro | |||||
10 of 31 patents shown. Soonest term end first, then patent number.
Pro members see all 31.
21 of these are in force and held by Pfizer Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.